Humana Inc (HUM) Stock Analysis
Verdict: HOLD
Recent 31% price surge driven by Medicare GLP-1 tailwinds has detached valuation from fundamentals—mean reversion is the primary risk.
Investment score: 48/100
Analysis as of
Is Humana Inc stock worth reviewing? AI model thesis
Avoid at current levels due to technical exhaustion and extreme valuation premium relative to peers and historical averages.
7-factor investment score
- Valuation: 40/100 (weight 20%)
- Financial Health: 35/100 (weight 15%)
- Technical Momentum: 65/100 (weight 15%)
- Earnings Quality: 75/100 (weight 15%)
- Insider Sentiment: 55/100 (weight 10%)
- Analyst Consensus: 30/100 (weight 10%)
- Risk-Adjusted Return: 50/100 (weight 15%)
Humana Inc opportunities and risks
What speaks for HUM
- Integrated Health Services Expansion
What speaks against HUM
- Valuation Disconnection from Peers
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| HUM | 43.5x | 0.4x | 20.4x | 14.0% | 0.8% | 2.6% |
| UNH | 32.3x | 0.9x | 19.1x | 18.8% | 2.7% | 5.1% |
| ELV | 17.9x | 0.5x | 12.7x | 23.2% | 2.6% | 7.1% |
| CNC | n/a | 0.2x | n/a | 14.9% | -3.3% | 18.7% |
| MOH | 68.8x | 0.3x | 17.5x | 8.5% | 0.4% | 2.1% |
| HQY | 35.0x | 5.9x | 18.8x | 72.7% | 17.3% | 6.2% |
| Peer median | 32.3x | 0.5x | 17.5x | 18.8% | 2.6% | 6.2% |
Frequently asked questions about Humana Inc (HUM)
Is HUM stock a good investment?
The cached TradeMates AI model rates Humana Inc as HOLD with an investment score of 48/100. Avoid at current levels due to technical exhaustion and extreme valuation premium relative to peers and historical averages. This is algorithmic model output, not personal investment advice.
Is HUM stock a buy?
The TradeMates model verdict for HUM is HOLD with an investment score of 48/100. Treat this as a model signal to review, not a personal buy recommendation.